Stereotaxis, Inc.
Stereotaxis, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 10 | 15 | 13 | 11 | 7 | 11 | 12 | 11 | 15 | 18 | 20 | 22 | |||||
Restricted Cash Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |||||
Accounts Receivable Net Current | 8 | 5 | 6 | 5 | 4 | 4 | 4 | 8 | 3 | 4 | 4 | 5 | |||||
Inventory Net | 13 | 10 | 10 | 10 | 10 | 10 | 8 | 9 | 9 | 8 | 8 | 7 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Assets Current | 38 | 36 | 34 | 27 | 22 | 26 | 26 | 29 | 28 | 31 | 33 | 36 | |||||
Property Plant And Equipment Net | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | |||||
Restricted Cash Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | 7 | 8 | - | - | - | - | |||||
Goodwill | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | - | - | - | - | |||||
Finite Lived Intangible Assets Net | 6 | 6 | 6 | 7 | 7 | 7 | 7 | - | - | - | - | - | |||||
Operating Lease Right Of Use Asset | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 1 | 5 | 5 | 5 | 5 | |||||
Prepaid Expense And Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 56 | 54 | 52 | 46 | 41 | 46 | 47 | 51 | 36 | 39 | 42 | 45 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 7 | 5 | 5 | 5 | 7 | 7 | 6 | 6 | 4 | 3 | 3 | 3 | |||||
Accrued Liabilities Current | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Contract With Customer Liability Current | 6 | 7 | 6 | 8 | 6 | 8 | 7 | 5 | 5 | 6 | 7 | 6 | |||||
Asset Acquisition Contingent Consideration Liabili… | - | - | - | - | 6 | 6 | 6 | 5 | - | - | - | - | |||||
Business Combination Contingent Consideration Liab… | 6 | 5 | 5 | 6 | - | - | 6 | - | - | - | - | - | |||||
Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 27 | 23 | 22 | 20 | 21 | 24 | 22 | 21 | 12 | 13 | 13 | 13 | |||||
Contract With Customer Liability Noncurrent | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Asset Acquisition Contingent Consideration Liabili… | - | - | - | - | 6 | 6 | 6 | 6 | - | - | - | - | |||||
Business Combination Contingent Consideration Liab… | 5 | 5 | 5 | 7 | - | - | 6 | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | |||||
Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 38 | 34 | 34 | 34 | 34 | 38 | 35 | 35 | 19 | 19 | 20 | 20 | |||||
Temporary Equity | |||||||||||||||||
Temporary Equity Carrying Amount Attributable To P… | - | - | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 606 | 604 | 597 | 584 | 573 | 571 | 568 | 565 | 559 | 557 | 554 | 551 | |||||
Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -594 | -589 | -583 | -578 | -571 | -568 | -562 | -554 | -548 | -542 | -538 | -533 | |||||
Stockholders Equity | 12 | 14 | 13 | 6 | 1 | 3 | 6 | 11 | 11 | 15 | 16 | 19 | |||||
Liabilities And Stockholders Equity | 56 | 54 | 52 | 46 | 41 | 46 | 47 | 51 | 36 | 39 | 42 | 45 | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | - | 10 | 10 | |||||
Temporary Equity Shares Authorized | - | - | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | |||||
Temporary Equity Shares Outstanding | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 98 | 97 | 95 | 91 | 86 | 86 | 85 | 85 | 83 | 82 | 81 | 81 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.78% | -3.24% | -31.89% | - | - | - | - | - | - | - | - | - |
| 2025 | 6.64% | 4.27% | 5.21% | 7.41% | 16.30% | 7.78% | -0.82% | -4.53% | -9.88% | -0.53% | 2.66% | 5.32% |
| 2024 | -8.13% | -15.79% | -13.88% | 10.47% | 6.81% | 1.57% | 5.74% | 13.40% | 15.79% | -9.29% | 10.38% | 16.39% |
| 2023 | - | - | - | - | - | - | 36.11% | 20.83% | 50.69% | -2.25% | -13.86% | -25.84% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.42 | 1.56 | 1.51 | 1.31 | 1.06 | 1.07 | 1.22 | 1.39 | 2.29 | 2.43 | 2.51 | 2.73 | |||||
| Quick Ratio | 0.91 | 1.05 | 1.05 | 0.78 | 0.55 | 0.62 | 0.75 | 0.91 | 1.46 | 1.72 | 1.82 | 2.14 | |||||
| Working Capital | 11.19M | 12.94M | 11.49M | 6.29M | 1.16M | 1.68M | 4.84M | 8.09M | 15.82M | 18.36M | 20.02M | 22.48M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 3.11 | 2.40 | 2.49 | 5.43 | 23.64 | 13.03 | 5.80 | 3.21 | 1.70 | 1.33 | 1.22 | 1.08 | |||||
| Interest Coverage TTM | -52.43 | -45.60 | -47.35 | -52.03 | -45.74 | -46.21 | -35.65 | -26.65 | -22.59 | -19.72 | -19.93 | -18.48 | |||||
| Debt Ratio | 0.69 | 0.64 | 0.64 | 0.75 | 0.84 | 0.82 | 0.76 | 0.68 | 0.53 | 0.49 | 0.48 | 0.45 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.62 | 0.63 | 0.65 | 0.62 | 0.82 | 0.65 | 0.61 | 0.53 | 0.56 | 0.60 | 0.56 | 0.59 | |||||
| Days Sales Outstanding TTM | 72.48 | 56.32 | 54.51 | 80.43 | 41.17 | 54.91 | 51.84 | 95.57 | 72.45 | 59.44 | 60.75 | 63.85 | |||||
| Receivables Turnover TTM | 5.04 | 6.48 | 6.70 | 4.54 | 8.87 | 6.65 | 7.04 | 3.82 | 5.04 | 6.14 | 6.01 | 5.72 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.22 | -0.22 | -0.24 | -0.26 | -0.27 | -0.29 | -0.28 | -0.27 | -0.26 | -0.25 | -0.27 | -0.25 | |||||
| Free Cash Flow Per Share TTM | -0.15 | -0.16 | -0.15 | -0.09 | -0.10 | -0.09 | -0.10 | -0.14 | -0.10 | -0.10 | -0.12 | -0.12 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 55.57% | 53.86% | 52.73% | 53.07% | 50.17% | 53.41% | 54.22% | 56.14% | 59.28% | 55.16% | 55.51% | 55.69% | |||||
| Operating Profit Margin TTM | -75.68% | -71.05% | -68.30% | -80.10% | -75.07% | -94.23% | -91.91% | -89.15% | -91.43% | -77.36% | -81.58% | -71.14% | |||||
| Net Profit Margin TTM | -73.20% | -68.49% | -66.85% | -79.61% | -74.41% | -93.33% | -89.33% | -91.13% | -93.03% | -78.28% | -82.39% | -70.60% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -5.46% | 13.40% | 20.28% | 19.61% | 33.94% | 1.50% | 0.55% | -14.79% | -19.14% | -2.01% | -4.89% | 1.44% | |||||
| Net Income Growth (1Y) | -7.01% | -16.78% | -9.99% | 4.49% | 7.13% | 21.02% | 9.02% | 9.99% | 6.63% | 1.53% | 12.33% | 10.59% | |||||
| EPS Growth (1Y) | -18.24% | -26.14% | -15.70% | -2.54% | 3.02% | 15.10% | 3.28% | 5.69% | 2.19% | -6.95% | 5.87% | 2.05% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -7.82 | -8.52 | -9.67 | -11.95 | -7.88 | -6.02 | -8.08 | -7.64 | -6.97 | -10.27 | -6.40 | -6.25 | |||||
| P/B TTM | 14.05 | 12.67 | 15.52 | 45.67 | 128.06 | 53.64 | 31.94 | 16.19 | 13.55 | 14.96 | 8.64 | 6.96 | |||||
| P/S TTM | 5.72 | 5.83 | 6.46 | 9.52 | 5.86 | 5.62 | 7.22 | 6.96 | 6.48 | 8.04 | 5.28 | 4.42 | |||||
| Market Cap | 172.05M | 181.96M | 209.20M | 286.16M | 186.46M | 154.47M | 194.22M | 175.08M | 153.92M | 217.87M | 141.23M | 130.30M | |||||
| Enterprise Value | 161.56M | 167.34M | 195.78M | 275.66M | 179.49M | 143.87M | 181.78M | 164.07M | 138.75M | 199.63M | 120.67M | 107.33M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -15.50M | -15.52M | -13.78M | -8.48M | -8.61M | -7.96M | -8.53M | -12.23M | -8.87M | -8.70M | -9.51M | -9.99M | |||||
| Net Debt | -10.49M | -14.62M | -13.42M | -10.51M | -6.97M | -10.60M | -12.44M | -11.01M | -15.16M | -18.25M | -20.56M | -22.98M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Stereotaxis, Inc. (STXS) — SEC Financial Statements & Analysis
Stereotaxis, Inc. (STXS) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Stereotaxis, Inc. trades on NYSE as: STXS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Stereotaxis, Inc. reported a -5.46% year-over-year revenue growth, a Gross Profit Margin of 55.57% (TTM), a Debt-to-Equity ratio of 3.11x, a Price-to-Sales (P/S) ratio of 5.72x (TTM), a Price-to-Book (P/B) ratio of 14.05x (TTM), at a market cap of $172.05M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -5.46%
- Gross Profit Margin TTM
- 55.57%
- Debt To Equity
- 3.11x
- P/S TTM
- 5.72x
- P/B TTM
- 14.05x
- Market Cap
- $172.05M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Stereotaxis, Inc. in?
Stereotaxis, Inc. (STXS) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What is STXS's market cap?
Stereotaxis, Inc. (STXS) has a market capitalization of $172.05M as of 2026-06-30.
What exchange does STXS trade on?
Stereotaxis, Inc. (STXS) trades on the NYSE.
Where is Stereotaxis, Inc. incorporated?
Stereotaxis, Inc. is incorporated in DE.